Brian Jones

Brian Jones

Company: Cedilla Therapeutics

Job title: Chief Scientific Officer


Leveraging Target-Intrinsic Characteristics to Modulate Protein Abundance 11:30 am

Principle and precedent for manipulation of regulatory networks and quality control systems to control protein abundance Application of experimental and informatics methods to discover druggable nodes that selectively modulate target abundance Leveraging mechanistic motifs across related targetsRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.